Sự thay đổi định lượng của các tế bào T γδ trong máu ngoại vi ở bệnh nhân và ý nghĩa lâm sàng của chúng

Davis MM et al (1984) A murine T cell receptor gene complex: isolation, structure and rearrangement. Immunol Rev 81:235–258 Saito H et al (1984) Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309(5971):757–762 Royer HD et al (1984) Genes encoding the Ti beta subunit of the antigen/MHC receptor undergo rearrangement during intrathymic ontogeny prior to surface T3-Ti expression. Cell 39(2 Pt 1):261–266 Fabbi M et al (1984) Homology of Ti alpha-subunit of a T-cell antigen-MHC receptor with immunoglobulin. Nature 312(5991):269–271 Saito H et al (1984) A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes. Nature 312(5989):36–40 Bank I et al (1986) A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 322(6075):179–181 Brenner MB et al (1986) Identification of a putative second T-cell receptor. Nature 322(6075):145–149 Chien YH, Konigshofer Y (2007) Antigen recognition by gammadelta T cells. Immunol Rev 215:46–58 Nedellec S et al (2010) Human Vgamma9Vdelta2 T cells: from signals to functions. Semin Immunol 22(4):199–206 Kabelitz D et al (2000) Antigen recognition by human gammadelta T lymphocytes. Int Arch Allergy Immunol 122(1):1–7 Palakodeti A et al (2013) The molecular basis for modulation of human Vgamma9Vdelta2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J Biol Chem 287(39):32780–32790 Bai L et al (2012) The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vdelta1 TCR. Eur J Immunol 42(9):2505–2510 Bonneville M et al (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 10(7):467–478 Born WK et al (2011) Peptide antigens for gamma/delta T cells. Cell Mol Life Sci 68(14):2335–2343 Hayday AC (2000) [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18:975–1026 Roark CL et al (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20(3):353–357 Pang DJ et al (2012) Understanding the complexity of gammadelta T-cell subsets in mouse and human. Immunology 136(3):283–290 Chen ZW (2013) Multifunctional immune responses of HMBPP-specific Vgamma2Vdelta2 T cells in M. tuberculosis and other infections. Cell Mol Immunol 10(1):58–64 Kabelitz D, He W (2012) The multifunctionality of human Vgamma9Vdelta2 gammadelta T cells: clonal plasticity or distinct subsets? Scand J Immunol 76(3):213–222 De Rosa SC et al (2004) Ontogeny of gamma delta T cells in humans. J Immunol 172(3):1637–1645 O’Leary JJ et al (1988) Expression of the human T cell antigen receptor complex in advanced age. Mech Ageing Dev 45(3):239–252 Re F et al (2005) Skewed representation of functionally distinct populations of Vgamma9Vdelta2 T lymphocytes in aging. Exp Gerontol 40(1–2):59–66 Caccamo N et al (2006) Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol 79(4):663–666 Michishita Y et al (2013) Age-associated alteration of gammadelta T-cell repertoire and different profiles of activation-induced death of Vdelta1 and Vdelta2 T cells. Int J Hematol 94(3):230–240 Roux A et al (2013) Differential impact of age and cytomegalovirus infection on the gammadelta T cell compartment. J Immunol 191(3):1300–1306 Colonna-Romano G et al (2002) Gamma/delta T lymphocytes are affected in the elderly. Exp Gerontol 37(2–3):205–211 Argentati K et al (2002) Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J Leukoc Biol 72(1):65–71 Hviid L et al (2000) High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. Int Immunol 12(6):797–805 Goodier M et al (1993) Gamma delta T cells in the peripheral blood of individuals from an area of holoendemic Plasmodium falciparum transmission. Trans R Soc Trop Med Hyg 87(6):692–696 Cairo C et al (2008) Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. Mol Immunol 45(11):3190–3197 Cairo C et al (2010) Impact of age, gender, and race on circulating gammadelta T cells. Hum Immunol 71(10):968–975 Worku S et al (1997) Higher proportion of CD8+ T cells in the blood in healthy adults from Ethiopia and Bangladesh compared with Sweden. Trans R Soc Trop Med Hyg 91(5):618–622 Polgar B et al (1999) The role of gamma/delta T cell receptor positive cells in pregnancy. Am J Reprod Immunol 41(4):239–244 Zheng NN et al (2011) Association between peripheral gammadelta T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa. J Acquir Immune Defic Syndr 57(2):92–100 Poles MA et al (2003) Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J Virol 77(19):10456–10467 Rossol R et al (1998) Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections. Br J Haematol 100(4):728–734 Dobmeyer TS et al (2002) Reciprocal alterations of Th1/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients. Br J Haematol 118(1):282–288 Fenoglio D et al (2009) Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113(26):6611–6618 Nilssen DE, Brandtzaeg P (2012) Intraepithelial gammadelta T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment. PLoS One 7(1):e29066 Poccia F et al (2009) Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells. AIDS 23(5):555–565 Ueta C et al (1994) Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun 62(12):5434–5441 Meraviglia S et al (2010) Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J Immunol 185(3):1770–1776 Li B et al (1996) Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol 157(9):4222–4229 Gioia C et al (2003) Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonaryA tuberculosis. Int J Immunopathol Pharmacol 16(3):247–252 Szereday L et al (2003) Gamma/delta T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy. Clin Exp Immunol 131(2):287–291 Peng MY et al (2008) Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol 5(3):203–208 Bourgarit A et al (2009) Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J Immunol 183(6):3915–3923 Worku S et al (1997) Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gammadelta+ T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 108(1):34–41 Hviid L et al (2001) Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun 69(5):3190–3196 Schwartz E et al (1996) Delayed expansion of V delta 2+ and V delta 1+ gamma delta T cells after acute Plasmodium falciparum and Plasmodium vivax malaria. J Allergy Clin Immunol 97(6):1387–1392 Perera MK et al (1994) Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms. J Exp Med 179(1):311–315 Darabi H et al (2002) Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy. Braz J Infect Dis 6(5):258–262 Prigione I et al (2006) T cell mediated immune responses to Toxoplasma gondii in pregnant women with primary toxoplasmosis. Microbes Infect 8(2):552–560 Knight A et al (2010) The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 116(12):2164–2172 Couzi L et al (2009) Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients. J Infect Dis 200(9):1415–1424 Dechanet J et al (1999) Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 103(10):1437–1449 Dechanet J et al (1999) Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis 179(1):1–8 Lafarge X et al (2001) Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 184(5):533–541 Vermijlen D et al (2010) Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 207(4):807–821 Pitard V et al (2008) Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 112(4):1317–1324 Macsween KF et al (2010) Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease. Clin Infect Dis 50(5):699–706 Hudnall SD et al (2003) Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Cytometry B Clin Cytom 55(1):22–28 Barcy S et al (2008) Gamma delta+ T cells involvement in viral immune control of chronic human herpesvirus 8 infection. J Immunol 180(5):3417–3425 Aoyagi M et al (2003) Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin Exp Immunol 131(2):312–317 Green S et al (1999) Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 180(5):1429–1435 Hara T et al (1992) Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest 90(1):204–210 Hoshina T et al (2012) NKRP1A+ gammadelta and alphabeta T cells are preferentially induced in patients with Salmonella infection. Hum Immunol 73(6):623–628 Islam D, Christensson B (2000) Disease-dependent changes in T-cell populations in patients with shigellosis. APMIS 108(4):251–260 Schneider T et al (1997) The number and proportion of Vgamma9 Vdelta2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infection. Clin Infect Dis 24(2):261–264 Klimpel GR et al (2003) Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells. J Immunol 171(3):1447–1455 Jouen-Beades F et al (1997) In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans. Infect Immun 65(10):4267–4272 Poquet Y et al (1998) Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun 66(5):2107–2114 Kroca M et al (2000) The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin Exp Immunol 120(2):280–284 Kroca M et al (2001) V gamma 9V delta 2 T cells in human legionellosis. Clin Diagn Lab Immunol 8(5):949–954 Caldwell CW et al (1995) Lymphocytosis of gamma/delta T cells in human ehrlichiosis. Am J Clin Pathol 103(6):761–766 Bertotto A et al (1997) Gamma delta T cells are decreased in the blood of children with Bordetella pertussis infection. Acta Paediatr 86(1):114–115 Watanabe H et al (2000) Psittacosis with increased gammadelta T cells in bronchoalveolar lavage fluid. Respirology 5(2):161–164 Caccamo N et al (2011) Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 118(1):129–138 Bertotto A et al (1993) Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur J Immunol 23(5):1177–1180 Kilic SS et al (2009) Gamma/delta T cells in patients with acute brucellosis. Clin Exp Med 9(2):101–104 Noguchi A et al (2011) Zoledronate-activated Vgamma9gammadelta T cell-based immunotherapy is feasible and restores the impairment of gammadelta T cells in patients with solid tumors. Cytotherapy 13(1):92–97 Bryant NL et al (2009) Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma. Neuro Oncol 11(4):357–367 Bilgi O et al (2008) Peripheral blood gamma-delta T cells in advanced-stage cancer patients. Adv Ther 25(3):218–224 Puan KJ et al (2009) Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma. Cancer Immunol Immunother 58(7):1095–1107 Bas M et al (2006) Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck. Oral Oncol 42(7):691–697 Kuroda H et al (2012) Decreased number and reduced NKG2D expression of Vdelta1 gammadelta T cells are involved in the impaired function of Vdelta1 gammadelta T cells in the tissue of gastric cancer. Gastric Cancer 15(4):433–439 Lee AJ et al (2012) Gammadelta T cells are increased in the peripheral blood of patients with gastric cancer. Clin Chim Acta 413(19–20):1495–1499 Campillo JA et al (2007) Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma. Dermatology 214(4):283–288 Provinciali M et al (2010) Persistent ex vivo low number and functional in vitro recovery of circulating gammadelta T cells after removal of a cutaneous primary melanoma. Scand J Immunol 72(2):142–149 Kobayashi H et al (2011) A new indicator of favorable prognosis in locally advanced renal cell carcinomas: gamma delta T-cells in peripheral blood. Anticancer Res 31(3):1027–1031 Bennouna J et al (2010) Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Cancer Immunol Immunother 59(10):1521–1530 Lang JM et al (2011) Pilot trial of interleukin-2 and zoledronic acid to augment gammadelta T cells as treatment for patients with refractory renal cell carcinoma. Cancer Immunol Immunother 60(10):1447–1460 Meraviglia S et al (2010) In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 161(2):290–297 Santini D et al (2009) In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients. Cancer Immunol Immunother 58(1):31–38 Dieli F et al (2007) Targeting human gamma}delta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 67(15):7450–7457 Kobayashi H et al (2007) Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother 56(4):469–476 Bennouna J et al (2008) Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 57(11):1599–1609 Sakamoto M et al (2011) Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded gammadeltaTcells: a phase I clinical study. J Immunother 34(2):202–211 Couzi L et al (2010) Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 21(1):181–188 Futagbi G et al (2007) Selective activation of TCR-gammadelta+ cells in endemic Burkitt’s lymphoma. Malar J 6:69 Braza MS et al (2010) Gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. J Immunol 184(1):134–140 Gertner-Dardenne J et al (2012) Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol 188(9):4701–4708 Lamb LS Jr et al (1999) Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1(1):7–19 Godder KT et al (2007) Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 39(12):751–757 Bank I et al (2003) Expansion of gammadelta T-cells in Behcet’s disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 141(1):33–40 Freysdottir J et al (1999) Gammadelta T cells in Behcet’s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118(3):451–457 Clemente A et al (2010) Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behcet’s disease patients and healthy controls. Immunol Lett 129(2):57–63 Yamashita N et al (1997) Role of gammadelta T lymphocytes in the development of Behcet’s disease. Clin Exp Immunol 107(2):241–247 Yasuoka H et al (2008) Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behcet’s disease and HLA-B51. Clin Exp Rheumatol 26(4 Suppl 50):S59–S63 Direskeneli H et al (2008) Thalidomide has both anti-inflammatory and regulatory effects in Behcet’s disease. Clin Rheumatol 27(3):373–375 Ahn JK et al (2005) Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behcet’s uveitis. Invest Ophthalmol Vis Sci 46(7):2458–2464 Freysdottir J et al (2006) Diversity of gammadelta T cells in patients with Behcet’s disease is indicative of polyclonal activation. Oral Dis 12(3):271–277 Brennan F et al (1989) Coordinate expansion of ‘fetal type’ lymphocytes (TCR gamma delta+ T and CD5+ B) in rheumatoid arthritis and primary Sjogren’s syndrome. Clin Exp Immunol 77(2):175–178 Kowal-Bielecka O et al (2001) Gamma delta-Lymphocytes in the peripheral blood of patients with rheumatoid arthritis–correlation with clinical and laboratory parameters of the disease and with the treatment used. Rocz Akad Med Bialymst 46:170–181 Smith MD et al (1990) T gamma delta cells and their subsets in blood and synovial tissue from rheumatoid arthritis patients. Scand J Immunol 32(6):585–593 Lunardi C et al (1992) T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis. Br J Rheumatol 31(8):527–530 Spadaro A et al (2004) Natural killer cells and gamma/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis. Clin Exp Rheumatol 22(4):389–394 Liu MF et al (1999) Distribution of double-negative (CD4− CD8−, DN) T subsets in blood and synovial fluid from patients with rheumatoid arthritis. Clin Rheumatol 18(3):227–231 Mitogawa T et al (1992) Frequency of gamma delta T cells in peripheral blood, synovial fluid, synovial membrane and lungs from patients with rheumatoid arthritis. Acta Med Okayama 46(5):371–379 Hoshino T et al (1996) TCR gamma delta+ T cells in peripheral blood of patients with adult Still’s disease. J Rheumatol 23(1):124–129 Macaubas C et al (2010) Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol 134(2):206–216 Kenna TJ et al (2012) Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum 64(5):1420–1429 Robak E et al (1999) Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus. Mediators Inflamm 8(6):305–312 Robak E et al (2001) Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Mediators Inflamm 10(4):179–189 Wang L et al (2012) Downregulation of CD94/NKG2A inhibitory receptor on decreased gammadelta T cells in patients with systemic lupus erythematosus. Scand J Immunol 76(1):62–69 Li X et al (2011) Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol 186(12):6693–6700 Chauhan SK et al (2006) T-cell receptor repertoire of circulating gamma delta T-cells in Takayasu’s arteritis. Clin Immunol 118(2–3):243–249 Seko Y (2000) Takayasu arteritis: insights into immunopathology. Jpn Heart J 41(1):15–26 Bendersky A et al (2010) Vgamma9+ gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis. Immunobiology 215(5):380–394 Ueda-Hayakawa I, et al. Circulating gamma/delta T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. J Dermatol Sci 69(1):54–60 Riccieri V et al (2005) Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol 32(2):283–286 Rinaldi L et al (2006) Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Brain 129(Pt 8):1993–2007 Chen Z, Freedman MS (2008) Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis. J Neuroimmunol 194(1–2):147–152 Schirmer L et al (2013) Enriched CD161high CCR6+ gammadelta T cells in the cerebrospinal fluid of patients with multiple sclerosis. JAMA Neurol 70(3):345–351 Pranzatelli MR et al (2004) Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus. J Pediatr Hematol Oncol 26(11):718–723 Pranzatelli MR et al (2004) B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62(9):1526–1532 Scelsa SN et al (2004) Blood gammadelta T cells, Campylobacter jejuni, and GM1 titers in Guillain–Barre syndrome. Muscle Nerve 30(4):423–432 Kretowski A et al (2000) Abnormal distribution of gammadelta T lymphocytes in Graves’ disease and insulin-dependent diabetes type 1. Arch Immunol Ther Exp (Warsz) 48(1):39–42 Toyabe S et al (2001) Oligoclonally expanding gammadelta T lymphocytes induce IgA switching in IgA nephropathy. Clin Exp Immunol 124(1):110–117 Chen KS et al (1996) Diminution of T cells with gamma delta receptor in the peripheral blood of allergic asthmatic individuals. Clin Exp Allergy 26(3):295–302 Zhao Y et al (2011) Altered expressions of helper T cell (Th)1, Th2, and Th17 cytokines in CD8(+) and gammadelta T cells in patients with allergic asthma. J Asthma 48(5):429–436 Krejsek J et al (1998) Decreased peripheral blood gamma delta T cells in patients with bronchial asthma. Allergy 53(1):73–77 Pons J et al (2005) Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease. Eur Respir J 25(3):441–446 Mota-Pinto A et al (2011) Regulatory T cells in elderly patients with asthma. J Investig Allergol Clin Immunol 21(3):199–206 Schauer U et al (1991) T cell receptor gamma delta bearing cells are decreased in the peripheral blood of patients with atopic diseases. Clin Exp Immunol 86(3):440–443 Hamzaoui A et al (2002) T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm 11(2):113–119 Krug N et al (2001) Cytokine profile of bronchoalveolar lavage-derived CD4(+), CD8(+), and gammadelta T cells in people with asthma after segmental allergen challenge. Am J Respir Cell Mol Biol 25(1):125–131 Spinozzi F et al (1996) Increased allergen-specific, steroid-sensitive gamma delta T cells in bronchoalveolar lavage fluid from patients with asthma. Ann Intern Med 124(2):223–227 Chen M et al (2012) Enhanced peripheral gammadeltaT cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression. J Clin Immunol 32(4):877–885 Chen M et al (2008) Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection. J Infect Dis 198(11):1643–1650 Ferri S et al (2010) A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 52(3):999–1007 Kiyici M et al (2006) Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection. J Gastroenterol Hepatol 21(6):963–969 Fernandez-Ruiz M et al (2009) Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation. Liver Transpl 15(10):1209–1216 Puig-Pey I et al (2010) Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int 23(10):1045–1055 Andreu-Ballester JC et al (2011) Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn’s disease. Dig Dis Sci 56(9):2613–2622 Andreu-Ballester JC et al (2013) Microsporidia and its relation to Crohn’s disease. A retrospective study. PLoS One 8(4):e62107 Soderstrom K et al (1996) Increased frequency of abnormal gamma delta T cells in blood of patients with inflammatory bowel diseases. J Immunol 156(6):2331–2339 Kelsen J et al (2011) Infliximab induces clonal expansion of gammadelta-T cells in Crohn’s disease: a predictor of lymphoma risk? PLoS One 6(3):e17890 Kerttula TO et al (1998) Circulating T lymphocyte subsets in coeliac disease (CoD) patients and healthy family members. Clin Exp Immunol 111(3):536–540 Camarero C et al (2000) Intraepithelial lymphocytes and coeliac disease: permanent changes in CD3−/CD7+ and T cell receptor gammadelta subsets studied by flow cytometry. Acta Paediatr 89(3):285–290 Calleja S et al (2011) Dynamics of non-conventional intraepithelial lymphocytes-NK, NKT, and gammadelta T-in celiac disease: relationship with age, diet, and histopathology. Dig Dis Sci 56(7):2042–2049 Jarvinen TT et al (2003) Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 98(6):1332–1337 Iltanen S et al (1999) Increased density of jejunal gammadelta+ T cells in patients having normal mucosa–marker of operative autoimmune mechanisms? Autoimmunity 29(3):179–187 Torrente F et al (2004) Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Helicobacter pylori gastritis. Am J Gastroenterol 99(4):598–605 Laggner U et al (2011) Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 187(5):2783–2793 Seung NR et al (2007) Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. J Cutan Pathol 34(12):903–911 Cai Y et al (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35(4):596–610 Cairo C et al (2005) Analysis of circulating gammadelta T cells in children affected by IgE-associated and non-IgE-associated allergic atopic eczema/dermatitis syndrome. Clin Exp Immunol 141(1):116–121 Katsuta M et al (2006) NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 176(12):7736–7744 Moins-Teisserenc HT et al (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 354(9190):1598–1603 Oswald E et al (2009) Reduced numbers of circulating gammadelta T cells in patients with bullous pemphigoid. Exp Dermatol 18(11):991–993 Suzuki S et al (1997) Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 110(3):500–508 Anane LH et al (2010) Phenotypic characterization of gammadelta T cells mobilized in response to acute psychological stress. Brain Behav Immun 24(4):608–614 Atanackovic D et al (2013) Acute psychological stress increases peripheral blood CD3(+)CD56(+) natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders. Stress 16(4):421–428 Matsushima A et al (2004) Early activation of gammadelta T lymphocytes in patients with severe systemic inflammatory response syndrome. Shock 22(1):11–15 Theodorou GL et al (2007) Effect of non-operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cells. Clin Exp Immunol 150(3):429–436 Venet F et al (2005) Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 33(12):2836–2840 Andreu-Ballester JC et al (2013) Association of gammadelta T cells with disease severity and mortality in septic patients. Clin Vaccine Immunol 20(5):738–746 Niehues T et al (2010) More than just SCID—the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol 135(2):183–192 Malan Borel I et al (2003) Gammadelta T cells and interleukin-6 levels could provide information regarding the progression of human renal allograft. Scand J Immunol 58(1):99–105 Yamaguchi T et al (2000) Changes in T-cell receptor subsets after cardiac surgery in children. Surg Today 30(10):875–878 Habermehl P et al (2003) Changes in lymphocyte subsets after cardiac surgery in children. Eur J Pediatr 162(1):15–21 Thompson K et al (2011) Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. Bone 49(1):140–145 Kalyan S et al (2013) Can peripheral blood gammadelta T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug-effects of aminobisphosphonate therapy. J Bone Miner Res 28(4):728–735 Matsumoto Y et al (1998) Peripheral deletion of gammadelta T cells in haemodialysis patients. Nephrol Dial Transplant 13(11):2861–2866 Roden AC et al (2008) Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase. Arch Pathol Lab Med 132(11):1774–1780